The Valley Desk

ArticleDrugs - real world outcomesPublished

Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Drugs - real world outcomes
Published
PubMed ID
41525027
PubMed Central ID
PMC13003052
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal